Skip to content

Anti D Isoimmunization Affecting Pregnancy C3698348

Published: July 22, 2026Updated: August 20, 2026

Rh factor incompatibility during pregnancy when an Rh-negative mother develops antibodies against fetal red blood cells. Managed with careful monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Varies

Pallor

(hematologic)

Jaundice

(hematologic)

Shortness of breath

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Rh Immunoglobulin Prophylaxis

Administration of anti-D immunoglobulin to Rh-negative mothers to prevent sensitization. Given at 28 weeks gestation and within 72 hours after potentially sensitizing events such as delivery, abortion, or trauma.

procedure
3

Titers and Fetal Monitoring

Serial measurement of maternal anti-D antibody titers combined with Doppler ultrasound assessment of fetal middle cerebral artery peak systolic velocity to detect and monitor fetal anemia.

monitoring

Additional treatment options

Intrauterine Transfusion

Direct transfusion of packed red blood cells to the fetus under ultrasound guidance when fetal anemia is confirmed. May require multiple procedures throughout pregnancy depending on severity.

procedure

Planned Delivery Management

Coordination of delivery timing and location based on fetal monitoring results. May include early delivery planning, availability of neonatal exchange transfusion, and delivery at a center with appropriate NICU resources.

surgical

Neonatal Phototherapy and Exchange Transfusion

Treatment of hyperbilirubinemia in affected newborns through intensive phototherapy and/or exchange transfusion to remove antibody-coated red cells and prevent kernicterus.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti D Isoimmunization Affecting Pregnancy C3698348?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American College of Obstetricians and Gynecologists. Prevention of Rh D Alloimmunization. Practice Bulletin No. 181. Obstet Gynecol. 2017.

guideline2017
2

Urbaniak SJ, Greiss MA. RhD haemolytic disease of the newborn. Vox Sang. 2000;79(1):31-38.

review2000
3

Crowther CA, Middleton P, McBain RD. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev. 2013;(2):CD000020.

meta_analysis2013
4

Moise KJ Jr, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol. 2012;119(6):1205-1216.

review2012

Medication Comparisons

Compare medications used to treat Anti D Isoimmunization Affecting Pregnancy C3698348. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy